News and events First antigen test pilot in low prevalence COVID-19 settings signals challenges for rollout Mar 2, 2021read more SARS-CoV-2 antibody signature Mar 1, 2021read more Mapping an effective immune response to COVID-19 Feb 11, 2021read more COVID variants and what they mean for the pandemic Feb 10, 2021read more New method to assist fast-tracking of vaccines for pre-clinical tests Jan 19, 2021read more New defence against dengue and emerging mosquito-borne viruses Jan 8, 2021read more Doherty Institute receives MRFF funding for COVID-19 vaccine Phase I clinical trial Jan 3, 2021read more Improving vaccination rates by dispelling mistrust and conspiracy Dec 17, 2020read more Sydney to undertake clinical studies of needle-free vaccine patch Nov 23, 2020read more University of Sydney to advance COVID-19 DNA vaccine to human trials Sep 24, 2020read more CSL signs agreement with Australian Government for UQ vaccine supply Sep 20, 2020read more « Older Entries Recent news First antigen test pilot in low prevalence COVID-19 settings signals challenges for rollout SARS-CoV-2 antibody signature Mapping an effective immune response to COVID-19 COVID variants and what they mean for the pandemic New method to assist fast-tracking of vaccines for pre-clinical tests The people behind AVRA A team of professionals across a wide range of disciplines has been assembled to launch AVRA, across 3 of Australia’s leading research Universities. read more
First antigen test pilot in low prevalence COVID-19 settings signals challenges for rollout Mar 2, 2021read more
Doherty Institute receives MRFF funding for COVID-19 vaccine Phase I clinical trial Jan 3, 2021read more